Annual CFI
$39.27 M
-$28.71 M-42.23%
December 31, 2023
Summary
- As of February 7, 2025, NXTC annual cash flow from investing activities is $39.27 million, with the most recent change of -$28.71 million (-42.23%) on December 31, 2023.
- During the last 3 years, NXTC annual CFI has fallen by -$4.25 million (-9.77%).
- NXTC annual CFI is now -42.23% below its all-time high of $67.98 million, reached on December 31, 2022.
Performance
NXTC Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$18.31 M
+$6.15 M+50.55%
September 30, 2024
Summary
- As of February 7, 2025, NXTC quarterly cash flow from investing activities is $18.31 million, with the most recent change of +$6.15 million (+50.55%) on September 30, 2024.
- Over the past year, NXTC quarterly CFI has increased by +$14.14 million (+339.86%).
- NXTC quarterly CFI is now -42.65% below its all-time high of $31.92 million, reached on June 30, 2022.
Performance
NXTC Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$52.51 M
+$8.03 M+18.05%
September 30, 2024
Summary
- As of February 7, 2025, NXTC TTM cash flow from investing activities is $52.51 million, with the most recent change of +$8.03 million (+18.05%) on September 30, 2024.
- Over the past year, NXTC TTM CFI has increased by +$13.24 million (+33.71%).
- NXTC TTM CFI is now -27.47% below its all-time high of $72.40 million, reached on March 31, 2023.
Performance
NXTC TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
NXTC Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -42.2% | +339.9% | +33.7% |
| 3 y3 years | -9.8% | +27.0% | -18.1% |
| 5 y5 years | +1382.1% | +110.5% | +117.3% |
NXTC Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -42.2% | +7.3% | -42.6% | +266.4% | -27.5% | +60.6% |
| 5 y | 5-year | -42.2% | +112.9% | -42.6% | +114.4% | -27.5% | +117.3% |
| alltime | all time | -42.2% | +112.9% | -42.6% | +110.5% | -27.5% | +117.3% |
NextCure Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $18.31 M(+50.6%) | $52.51 M(+18.1%) |
| Jun 2024 | - | $12.16 M(-32.0%) | $44.48 M(+14.0%) |
| Mar 2024 | - | $17.88 M(+329.6%) | $39.03 M(-0.6%) |
| Dec 2023 | $39.27 M(-42.2%) | $4.16 M(-59.5%) | $39.27 M(-0.8%) |
| Sep 2023 | - | $10.28 M(+53.2%) | $39.58 M(-16.1%) |
| Jun 2023 | - | $6.71 M(-63.0%) | $47.19 M(-34.8%) |
| Mar 2023 | - | $18.12 M(+305.6%) | $72.40 M(+6.5%) |
| Dec 2022 | $67.98 M(+85.7%) | $4.47 M(-75.0%) | $67.98 M(+29.5%) |
| Sep 2022 | - | $17.89 M(-44.0%) | $52.51 M(+7.1%) |
| Jun 2022 | - | $31.92 M(+133.0%) | $49.04 M(+49.9%) |
| Mar 2022 | - | $13.70 M(-224.6%) | $32.70 M(-10.6%) |
| Dec 2021 | $36.60 M | -$11.00 M(-176.3%) | $36.60 M(-42.9%) |
| Sep 2021 | - | $14.41 M(-7.5%) | $64.10 M(+2.1%) |
| Jun 2021 | - | $15.59 M(-11.4%) | $62.79 M(+12.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $17.60 M(+6.7%) | $55.75 M(+28.1%) |
| Dec 2020 | $43.52 M(-114.3%) | $16.50 M(+25.9%) | $43.52 M(-143.5%) |
| Sep 2020 | - | $13.10 M(+53.3%) | -$100.14 M(-65.2%) |
| Jun 2020 | - | $8.55 M(+59.1%) | -$287.93 M(-3.3%) |
| Mar 2020 | - | $5.37 M(-104.2%) | -$297.62 M(-2.1%) |
| Dec 2019 | -$303.92 M(+9822.4%) | -$127.16 M(-27.2%) | -$303.92 M(+70.1%) |
| Sep 2019 | - | -$174.69 M(>+9900.0%) | -$178.67 M(+4077.4%) |
| Jun 2019 | - | -$1.13 M(+21.1%) | -$4.28 M(+21.1%) |
| Mar 2019 | - | -$935.00 K(-50.9%) | -$3.53 M(+15.3%) |
| Dec 2018 | -$3.06 M(-64.6%) | -$1.90 M(+522.2%) | -$3.06 M(+164.3%) |
| Sep 2018 | - | -$306.00 K(-21.1%) | -$1.16 M(+35.9%) |
| Jun 2018 | - | -$388.00 K(-16.6%) | -$853.00 K(+83.4%) |
| Mar 2018 | - | -$465.00 K | -$465.00 K |
| Dec 2017 | -$8.65 M | - | - |
FAQ
- What is NextCure annual cash flow from investing activities?
- What is the all time high annual CFI for NextCure?
- What is NextCure annual CFI year-on-year change?
- What is NextCure quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for NextCure?
- What is NextCure quarterly CFI year-on-year change?
- What is NextCure TTM cash flow from investing activities?
- What is the all time high TTM CFI for NextCure?
- What is NextCure TTM CFI year-on-year change?
What is NextCure annual cash flow from investing activities?
The current annual CFI of NXTC is $39.27 M
What is the all time high annual CFI for NextCure?
NextCure all-time high annual cash flow from investing activities is $67.98 M
What is NextCure annual CFI year-on-year change?
Over the past year, NXTC annual cash flow from investing activities has changed by -$28.71 M (-42.23%)
What is NextCure quarterly cash flow from investing activities?
The current quarterly CFI of NXTC is $18.31 M
What is the all time high quarterly CFI for NextCure?
NextCure all-time high quarterly cash flow from investing activities is $31.92 M
What is NextCure quarterly CFI year-on-year change?
Over the past year, NXTC quarterly cash flow from investing activities has changed by +$14.14 M (+339.86%)
What is NextCure TTM cash flow from investing activities?
The current TTM CFI of NXTC is $52.51 M
What is the all time high TTM CFI for NextCure?
NextCure all-time high TTM cash flow from investing activities is $72.40 M
What is NextCure TTM CFI year-on-year change?
Over the past year, NXTC TTM cash flow from investing activities has changed by +$13.24 M (+33.71%)